Skip to content

Gamelin Erick

Reporting owner on Forms 3, 4 and 5, CIK 1950551.

Gamelin Erick reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-19.

Issuers

IssuerRoles in the latest filingFilingsLast filed
ACRV · Acrivon Therapeutics, Inc.CIK 1781174officer (Chief Development Officer)12026-11-19

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
ACRV · Acrivon Therapeutics, Inc.Common Stock2026-11-17S sold-416$1.4552,176Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0000905148-26-005053 Acrivon Therapeutics, Inc.2026-11-19